Axial Therapeutics Patents – Key Insights and Stats

Axial Therapeutics has a total of 28 patents globally, out of which 7 have been granted. Of these 28 patents, more than 92% patents are active. The United States of America is where Axial Therapeutics has filed the maximum number of patents, followed by Australia and Canada. Parallelly, the United States of America seems to be the main focused R&D centre of Axial Therapeutics.

Axial Therapeutics was founded in the year 2016 by David Donabedian, PhD, Jeffrey Young and Michelle Dipp. The company is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System.

Do read about some of the most popular patents of Axial Therapeutics which have been covered by us in this article and also you can find Axial Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Axial Therapeutics patent portfolio.

How many patents does Axial Therapeutics have?

Axial Therapeutics has a total of 28 patents globally. These patents belong to 7 unique patent families. Out of 28 patents, 26 patents are active.

How Many Patents did Axial Therapeutics File Every Year?

Axial Therapeutics Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAxial Therapeutics Applications FiledAxial Therapeutics Patents Granted
202233
2021133
202011
201811

How many Axial Therapeutics patents are Alive/Dead?

Axial Therapeutics Patents Portfolio

How Many Patents did Axial Therapeutics File in Different Countries?

Axial Therapeutics Worldwide Patents

Where are Research Centres of Axial Therapeutics Patents Located?

The research Centre of all Axial Therapeutics Patents is the United States of America.

What Percentage of Axial Therapeutics US Patent Applications were Granted?

Axial Therapeutics (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 100.0%.

Below are the key stats of Axial Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Axial Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Knobbe Martens Olson & Bear Llp3100.00%
Wolf Greenfield & Sacks Pc2100.00%

List of Axial Therapeutics Patents

Axial Therapeutics PatentsTitle
HK40075263AGut-selective sequestering agents for the treatment and prevention of autism and related disorders
AU2021280287A1TLR2 modulator compounds, pharmaceutical compositions and uses thereof
BR112022024071A2TLR2 MODULATOR compounds, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
US11505528B2Inhibitors of microbially induced amyloid
EP4087560A2Inhibitors of microbially induced amyloid
AU2021206267A1Inhibitors of microbially induced amyloid
NZ758692BGut-selective sequestering agents for the treatment and prevention of autism and related disorders
WO2022098879A1Sustained release solid dosage forms for modulating the colonic microbiome
US20220133634A1Sustained release solid dosage forms for modulating the colonic microbiome
NZ785988AGut-selective sequestering agents for the treatment and prevention of autism and related disorders
US11278498B2Sustained release solid dosage forms for modulating the colonic microbiome
US20220040145A1Inhibitors of microbially induced amyloid
AU2022200220A1Gut-selective sequestering agents for the treatment and prevention of autism and related disorders
WO2021242923A1Tlr2 modulator compounds, pharmaceutical compositions and uses thereof
CA3177546A1Tlr2 modulator compounds, pharmaceutical compositions and uses thereof
NZ794925ATLR2 modulator compounds, pharmaceutical compositions and uses thereof
US11147792B2Inhibitors of microbially induced amyloid
US20210317508A1Methods and apparatus for determining risk of autism spectrum disorder
AU2021206871B2Gut-selective sequestering agents for the treatment and prevention of autism and related disorders
WO2021142333A3Inhibitors of microbially induced amyloid
CA3167292A1Inhibitors of microbially induced amyloid
NZ791097AInhibitors of microbially induced amyloid
EP3664822A4Inhibitors of microbially induced amyloid
AU2018243836B9Gut-selective sequestering agents for the treatment and prevention of autism and related disorders
EP3600349A4Gut-selective sequestering agents for the treatment and prevention of autism and related disorders
US10617718B2Gut-selective sequestering agents for the treatment and prevention of autism and related disorders
CA3108484A1Inhibitors of microbially induced amyloid
CA3095724A1Gut-selective sequestering agents for the treatment and prevention of autism and related disorders

What are Axial Therapeutics key innovation segments?

What Technologies are Covered by Axial Therapeutics?

The chart below distributes patents filed by Axial Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Axial Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Axial Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by the Axial Therapeutics?

Table of Content

Insights you may find interesting

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.